Our work
Consult and speak
Novartis Pharmaceuticals
Novartis, relaunching Xiidra, a dry eye treatment, in the United States.
$35M+sales in the first month
+15%prescription share
+30%awareness among prescribers
+20%website traffic
The goal
Relaunch the brand with no in-person sales force during the COVID-19 pandemic.
What we did
- Content creation
- Digital marketing and advertising
- Print publishing and media partnerships
- A virtual live event
- Analytics to guide content and spend
The work
